HomeTOP STORIESMyriad Genetics outlines $860M–$880M revenue target for 2026 while advancing cancer care... Myriad Genetics outlines $860M–$880M revenue target for 2026 while advancing cancer care continuum strategy By rogerjudd February 24, 2026 FacebookTwitterPinterestWhatsApp Post Content Previous articleAllison outlines $5.575B–$5.925B 2026 sales target following Dana Off-Highway acquisition integrationNext articleBWXT outlines $3.75B 2026 revenue target while expanding commercial nuclear and medical growth latest articles The inflation process has shifted even as headline CPI declined – Federal Reserve Cerrado Gold reports Q4 results As H-1B Visa Program Changes, Skilled Foreign Workers Consider Leaving U.S. They Get Drunk Without Drinking: What It’s Like to Have Auto-brewery Syndrome Parents Who Borrowed for Children’s College Face Looming Deadline Watch: Artemis II’s journey so far… in 85 seconds explore more The inflation process has shifted even as headline CPI declined – Federal Reserve Cerrado Gold reports Q4 results As H-1B Visa Program Changes, Skilled Foreign Workers Consider Leaving U.S. They Get Drunk Without Drinking: What It’s Like to Have Auto-brewery Syndrome Parents Who Borrowed for Children’s College Face Looming Deadline Watch: Artemis II’s journey so far… in 85 seconds
